Two other veterans from Minnesota with Parkinson and myself met with Congressmen Tim Wilz MN and
Bob Filner CA in Rochester a couple of weeks ago. Filner is the Chairman of The Veterans Affairs Committee, they believe that Parkinson is being caused by Agent Orange. Filner is drawning up legislation to put Parkinson on the presumptive list of diseases caused by Agent Orange. What we need now is everyone to contact their Senators and Congressmen and ask them to support this legislation. We need this done ASAP, have your friends and relatives do the same. This is very important to get the word to these people. If you have trouble sending this message have someone help you do it, but get is done.
We now have near 50 in our group of veterans with Parkinson and Agent Orange exposer. If you are interested in joining us contact me.


Semper Fi,

Steve


"ADAPT,IMPROVISE, OVERCOME"

I was at a meeting with Bob Filner yesterday, and as you say, he strongly believes that Parkinsons is caused by Agent Orange, and is doing everything in his power to add it to the list of Agent Orange diseases. He is very agitated and disappointed that the VA choses to fiddle around for years while the vets suffer, making no real strides to even make a decision. That guy is certainly one us vets should be very happy that he is on our side.

Important reading

Hubble JP, Kurth JH, Glatt SL, Kurth MC, Schellenberg GD, Hassanein RE, Lieberman A, Koller WC 1998. Gene-toxin interaction as a putative risk factor for Parkinson’s disease with dementia. Neuroepidemiology 17:96–104.

IOM (Institute of Medicine). 1994. Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam. Washington, DC: National Academy Press.

IOM. 1996. Veterans and Agent Orange: Update 1996. Washington, DC: National Academy Press.

IOM. 1999. Veterans and Agent Orange: Update 1998. Washington, DC: National Academy Press.



Jimenez-Jimenez FJ, Mateo D, Gimenez-Roldan S. 1992. Exposure to well water and pesticides in Parkinson’s disease: a case-control study in the Madrid area. Movement Disorders 7:149–152.



Koller W, Vetere-Overfield B, Gray C, Alexander C, Chin T, Dolezal J, Hassanein R, Tanner C. 1990. Environmental risk factors in Parkinson’s disease. Neurology 40:1218–1221.

Kuopio A, Marttila RJ, Helenius H, Rinne UK. 1999. Environmental risk factors in Parkinson’s disease. Movement Disorders 14:928–939.



Langston, JW. 1998. Epidemiology versus genetics in Parkinson’s disease: progress in resolving an age-old debate. Annals of Neurology 44(Suppl 1):S45–S52.

Le Couteur DG, McLean AJ, Taylor MC, Woodham BL, Board PG. 1999. Pesticides and Parkinson’s disease. Biomedicine and Pharmacotherapy 53:122–130.

Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY, Chen RC. 1997. Environmental risk factors and Parkinson’s disease: a case-control study in Taiwan. Neurology 48:1583–1588.



McCann SJ, LeCouteur DG, Green AC Brayne C, Johnson AG, Chan D, McManus ME, Pond SM. 1998. The epidemiology of Parkinson’s disease in an Australian population. Neuroepidemiology 17:310–317.

McLeod JG. 1995. Investigation of peripheral neuropathy. Journal of Neurology, Neurosurgery and Psychiatry 58:274–283.

Menegon A, Board PG, Blackburn AC, Mellick GD, LeCouteur DG. 1998. Parkinson’s disease, pesticides, and glutathione transferase polymorphisms. Lancet 352:1344–1346.

Morano A, Jimenez-Jimenez FJ, Molina JA, Antolin MA. 1994. Risk-factors for Parkinson’s disease: case-control study in the province of Caceres, Spain. Acta Neurologica Scandinavica 89(3):164–170.



Pirart J. 1978. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Di

abetes Care 1:168–188.
Priyadarshi A, Khuder SA, Schaub EA, Shrivastava S. 2000. A meta-analysis of Parkison’s disease and exposure to pesticides. Neurotoxicology 21(4):435–440.



Ritz B, Yu F. 2000. Parkinson’s disease mortality and pesticide exposure in California 1984–1994. International Journal of Epidemiology 29:323–329.



Schulte PA, Burnett CA, Boeniger MF, Johnson J. 1996. Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991. American Journal of Public Health 86(9):1281–1288.

Seidler A, Hellenbrand W, Robra BP, Vieregge P, Nischan P, Joerg J, Oertel WH, Ulm G, Schneider E. 1996. Possible environmental, occupational, and other etiologic factors for Parkinson’s disease: a case-control study in Germany. Neurology 46(5):1275–1284.

Semchuk KM, Love EJ, Lee RG. 1992. Parkinson’s disease and exposure to agricultural work and pesticide chemicals. Neurology 42:1328–1335.

Smargiassi A, Mutti A, DeRosa A, DePalma G, Negrotti A, Calzetti S. 1998. A case-control study of occupational and environment risk factors for Parkinson’s disease in the Emilia-Romagna region of Italy. Neurotoxicology 19:709–712.

Stern M, Dulaney E, Gruber SB, Golbe L, Bergen M, Hurtig H, Gollomp S, Stolley P. 1991. The epidemiology of Parkinson’s disease. A case-control study of young-onset and old-onset patients. Archives of Neurology 48:903–907.

Tanner CM, Chen B, Wang W, Peng M, Liu Z, Liang X, Kao LC, Gilley DW, Goetz CG, Schoenberg BS. 1989. Environmental factors and Parkinson’s disease: a case-control study in China. Neurology 39:660–664.

Taylor CA, Saint-Hilaire MH, Cupples LA, Thomas CA, Burchard AE, Feldman RG, Myers RH. 1999. Environmental, medical, and family history risk factors for Parkinson’s disease: a New England-based case control study. American Journal of Medical Genetics (Neuropsychiatric Genetics) 88:742–749.

Tuchsen F, Jensen AA. 2000. Agricultural work and the risk of Parkinson’s disease in Denmark, 1981–1993. Scandinavian Journal of Work, Environment, and Health 26:359–362.



Wechsler LS, Checkoway H, Franklin GM, Costa LG. 1991. A pilot study of occupational and environment risk factors for Parkinson’s disease. NeuroToxicology 12:387–392.

Weiss B. 2000. Vulnerability to pesticide neurotoxicity is a lifetime issue. Neurotoxicology 21(1– 2):67–73.

Wong GF, Gray CS, Hassanein RS, Koller WC. 1991. Environmental risk factors in siblings with Parkinson’s disease. Archives of Neurology 48:287–289.